Assignee
GUANGZHOU INNOCARE PHARMA TECH CO LTD
CN·6 granted patents·1 pending application·3 citations·filing 2017–2024
Top patents by PatentIndex Score
7 records- 0186US2025059176A1Substituted nicotinimide inhibitors of btk for treating cancerGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 0285US12162873B2Substituted nicotinimide inhibitors of BTK for treating cancerGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2023·Granted Dec 10, 2024·0 cites·5 claims
- 0384US10301297B2Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune diseaseGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2018·Granted May 28, 2019·3 cites·8 claims
- 0479US11840513B2Substituted nicotinimide inhibitors of BTK for treating cancerGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2022·Granted Dec 12, 2023·0 cites·8 claims
- 0569US11345695B2Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune diseaseGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2019·Granted May 31, 2022·0 cites·8 claims
- 0653US12448382B2Heterocyclic compounds for mediating tyrosine kinase 2 activityGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2021·Granted Oct 21, 2025·0 cites·21 claims
- 0746US10752631B2Heterocyclic compounds as FGFR inhibitorsGUANGZHOU INNOCARE PHARMA TECH CO LTD·Filed 2017·Granted Aug 25, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU INNOCARE PHARMA TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →